Načítá se...
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
PURPOSE: To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS: Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by randomization. Twelve eyes in each group completed 6 months of regular follow-up a...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Ophthalmological Society
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2882078/ https://ncbi.nlm.nih.gov/pubmed/20532141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3341/kjo.2010.24.3.155 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|